• About us
• Contact

Advertisement

Document › Details

AB Science S.A.. (3/31/17). "Press Release: AB Science Announces the Success of a Private Placement [Not for US, CA or JP]". Paris.

	Organisation	AB Science S.A. (NYSE Euronext - FR0010557264 - AB)
	Group	AB Science (Group)
	Organisation 2	Chardan Capital Markets LLC
	Product	investment banking
	Product 2	kinase inhibitor
	Index term	AB Science–SEVERAL: investment, 201703 private placement €19m net €18.43m w 1.24m new shares at €15.3/share

Record changed: 2023-06-05

Advertisement

More documents for AB Science (Group)

• [1] AB Science S.A.. (2/28/22). "Press Release: Financing of 8.5 Million Dollars through the Issuance of Convertible Bonds with Attached Warrants (with a Conversion Price of EUR 14.0) [Not for US, CA, AU or JP]". Paris....
• [2] AB Science S.A.. (5/12/17). "Press Release: AB Science Announces that ANSM Requested the Temporary Suspension of Clinical Studies Conducted in France Following Deviations from Good Clinical Practice (GCP) Standards". Paris....
• [3] AB Science S.A.. (3/27/17). "Press Release: AB Science Announces the Success of a Private Placement [Not for US, CA or JP]". Paris....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2023. Made in Germany.